Clinical trials
Optic Nerve Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Recruiting | 12 |
| Unknown status | 10 |
| Not yet recruiting | 8 |
| Terminated | 6 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Duke University | 3 |
| Bayer | 2 |
| Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | 2 |
| Clene Nanomedicine | 2 |
| Fondation Ophtalmologique Adolphe de Rothschild | 2 |
| MD Stem Cells | 2 |
| Stanford University | 2 |
| University of Magdeburg | 2 |
| University of Miami | 2 |
| Adiyaman University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Optic Nerve Diseases | 60 |
| Glaucoma | 15 |
| Optic Neuropathy, Ischemic | 12 |
| Retinal Diseases | 12 |
| Optic Neuritis | 7 |
| Macular Degeneration | 6 |
| Eye Diseases | 5 |
| Optic Atrophy, Hereditary, Leber | 5 |
| Optic Nerve Injuries | 5 |
| Vision Disorders | 5 |
Trials
Showing 26 to 50 of 60. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.